Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Evelyn R Hermes-DeSantis"'
Autor:
Evelyn R Hermes-DeSantis, Robert T Hunter, Julie Welch, Roma Bhavsar, Daniel Boulos, Marie-Ange Noue
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 6, p e25868 (2021)
BackgroundHealth care professionals (HCPs) routinely have questions concerning the medications they are recommending. There are numerous resources available; however, each has its own advantages and disadvantages. ObjectiveThe purpose of this survey
Externí odkaz:
https://doaj.org/article/19896c7987c94da2b544d1a8ffc4675c
Autor:
Pete Guillot, John Shea, Scarlett Shoemaker, Michael Rocco, Michael DeLuca, Rena Rai, Evelyn R. Hermes-DeSantis
Publikováno v:
Pharmaceutical Medicine. 37:111-119
Autor:
Dominick Albano, Farah Pragga, Rena Rai, Teresa Flowers, Prachi Parmar, Susan Wnorowski, Evelyn R. Hermes-DeSantis
Publikováno v:
Therapeutic Innovation & Regulatory Science. 56:405-414
Medical information (MI) professionals are primarily responsible for researching and responding to unsolicited requests for information on their company’s product(s). In an effort to set a standard for quality, the Pharma Collaboration for Transpar
Autor:
Evelyn R. Hermes-DeSantis, Patrick Reilly, Sandeep Gantotti, Stacey Follman, Yesha D. Patel, Dominick Albano
Publikováno v:
The Journal for Nurse Practitioners. 17:840-845
Information concerning medications is a necessity for nurse practitioners and other clinicians. Pharmaceutical companies’ Medical Information services are an option for evidence-based, scientifically balanced information. This survey elicited clini
Autor:
Ahsan Jamil, Renee M Johnson, Anne Flanigan-Minnick, Hamza Sarwar, Bindi Patel, Tiffany Huang, Evelyn R. Hermes-DeSantis, Susan Wnorowski, Sonia Kaur Sandhu, Mabel M Cortes, Patrick Reilly, Alysa Redlich, Elissa Vine, Chang Woo Han, Rita A. Haydar
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:1303-1311
The Medical Information Department of a pharmaceutical manufacturer provides written scientific responses to unsolicited requests from healthcare providers for information on products that extends beyond the product labeling (off-label). These scient
Publikováno v:
Therapeutic innovationregulatory science. 56(3)
Background Understanding the ways that healthcare providers (HCPs) utilize medical information received from the pharmaceutical industry is important so that the information can be tailored and customized to meet the HCPs needs. Additionally, this un
Publikováno v:
Vaccines, Vol 5, Iss 3, p 25 (2017)
This review aims to evaluate the literature on the safety and efficacy of novel toxoid vaccines for the prophylaxis of Clostridium difficile infections (CDI) in healthy adults. Literature searches for clinical trials were performed through MEDLINE, C
Externí odkaz:
https://doaj.org/article/c8806dc12e3b42059ac3a50d052c448a
Publikováno v:
Journal of pharmacy practice. 35(2)
Peanut allergy (PA) is a food allergy that causes an IgE-mediated type I hypersensitivity reaction. PA has become an increasing public health burden, with 2% of American children reported to have this condition in 2010. Current guidelines recommend a
Autor:
Joseph Barone, michael toscani, Evelyn R. Hermes-DeSantis, Savan Patel, Srivarshini Kanukollu, Michele Bender, Kenneth Hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a322611449f755b9da7009d0ba6b3e03
https://doi.org/10.26226/morressier.5e20352214799ab1e7e07b41
https://doi.org/10.26226/morressier.5e20352214799ab1e7e07b41
Autor:
Evelyn R. Hermes-DeSantis, James Young, Jacqueline Byun, Roma Bhavsar, Patrick Reilly, Michael Toscani
Publikováno v:
Therapeutic innovationregulatory science. 54(6)
One of the main roles of the medical information (MI) department within a pharmaceutical company is to develop scientific/standard response documents (SRDs) to provide comprehensive medical information to healthcare providers (HCPs). This study seeks